Chaves C, Dos Santos R, Dursun S, Tusconi M, Carta M, Brietzke E
Front Psychiatry. 2024; 15:1485337.
PMID: 39568756
PMC: 11576444.
DOI: 10.3389/fpsyt.2024.1485337.
James E, Keppler J, Robertshaw T, Sessa B
Hum Psychopharmacol. 2022; 37(3):e2835.
PMID: 35175662
PMC: 9286861.
DOI: 10.1002/hup.2835.
Schlag A, Aday J, Salam I, Neill J, Nutt D
J Psychopharmacol. 2022; 36(3):258-272.
PMID: 35107059
PMC: 8905125.
DOI: 10.1177/02698811211069100.
Barker S
Psychopharmacology (Berl). 2022; 239(6):1749-1763.
PMID: 35064294
PMC: 8782705.
DOI: 10.1007/s00213-022-06065-0.
Machado Brito-da-Costa A, Dias-da-Silva D, Gomes N, Dinis-Oliveira R, Madureira-Carvalho A
Pharmaceuticals (Basel). 2020; 13(11).
PMID: 33114119
PMC: 7690791.
DOI: 10.3390/ph13110334.
Toxicological Aspects and Determination of the Main Components of Ayahuasca: A Critical Review.
Simao A, Goncalves J, Duarte A, Barroso M, Cristovao A, Gallardo E
Medicines (Basel). 2019; 6(4).
PMID: 31635364
PMC: 6963515.
DOI: 10.3390/medicines6040106.
Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain.
Dean J, Liu T, Huff S, Sheler B, Barker S, Strassman R
Sci Rep. 2019; 9(1):9333.
PMID: 31249368
PMC: 6597727.
DOI: 10.1038/s41598-019-45812-w.
The Varieties of the Psychedelic Experience: A Preliminary Study of the Association Between the Reported Subjective Effects and the Binding Affinity Profiles of Substituted Phenethylamines and Tryptamines.
Zamberlan F, Sanz C, Martinez Vivot R, Pallavicini C, Erowid F, Erowid E
Front Integr Neurosci. 2018; 12:54.
PMID: 30467466
PMC: 6235949.
DOI: 10.3389/fnint.2018.00054.
N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function.
Barker S
Front Neurosci. 2018; 12:536.
PMID: 30127713
PMC: 6088236.
DOI: 10.3389/fnins.2018.00536.
Indolethylamine--methyltransferase Polymorphisms: Genetic and Biochemical Approaches for Study of Endogenous ,-dimethyltryptamine.
Dean J
Front Neurosci. 2018; 12:232.
PMID: 29740267
PMC: 5924808.
DOI: 10.3389/fnins.2018.00232.
Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.
Dos Santos R, Bouso J, Hallak J
Ther Adv Psychopharmacol. 2017; 7(4):141-157.
PMID: 28540034
PMC: 5433617.
DOI: 10.1177/2045125316689030.
The Endogenous Hallucinogen and Trace Amine N,N-Dimethyltryptamine (DMT) Displays Potent Protective Effects against Hypoxia via Sigma-1 Receptor Activation in Human Primary iPSC-Derived Cortical Neurons and Microglia-Like Immune Cells.
Szabo A, Kovacs A, Riba J, Djurovic S, Rajnavolgyi E, Frecska E
Front Neurosci. 2016; 10:423.
PMID: 27683542
PMC: 5021697.
DOI: 10.3389/fnins.2016.00423.
NPS: Medical Consequences Associated with Their Intake.
Schifano F, Orsolini L, Papanti D, Corkery J
Curr Top Behav Neurosci. 2016; 32:351-380.
PMID: 27272067
DOI: 10.1007/7854_2016_15.
Neuropharmacology of N,N-dimethyltryptamine.
Carbonaro T, Gatch M
Brain Res Bull. 2016; 126(Pt 1):74-88.
PMID: 27126737
PMC: 5048497.
DOI: 10.1016/j.brainresbull.2016.04.016.
Pharmacological evidence of neuro-pharmacological activity of Acacia tortilis leaves in mice.
Alharbi W, Azmat A
Metab Brain Dis. 2016; 31(4):881-5.
PMID: 27025511
DOI: 10.1007/s11011-016-9821-2.
Ayahuasca and cancer treatment.
Schenberg E
SAGE Open Med. 2016; 1:2050312113508389.
PMID: 26770688
PMC: 4687784.
DOI: 10.1177/2050312113508389.
Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities.
Szabo A
Front Immunol. 2015; 6:358.
PMID: 26236313
PMC: 4500993.
DOI: 10.3389/fimmu.2015.00358.
Novel psychoactive substances of interest for psychiatry.
Schifano F, Orsolini L, Duccio Papanti G, Corkery J
World Psychiatry. 2015; 14(1):15-26.
PMID: 25655145
PMC: 4329884.
DOI: 10.1002/wps.20174.
On the transmethylation hypothesis: stress, N,N-dimethyltryptamine, and positive symptoms of psychosis.
Grammenos D, Barker S
J Neural Transm (Vienna). 2014; 122(6):733-9.
PMID: 25362533
DOI: 10.1007/s00702-014-1329-5.
Noncompetitive inhibition of indolethylamine-N-methyltransferase by N,N-dimethyltryptamine and N,N-dimethylaminopropyltryptamine.
Chu U, Vorperian S, Satyshur K, Eickstaedt K, Cozzi N, Mavlyutov T
Biochemistry. 2014; 53(18):2956-65.
PMID: 24730580
PMC: 4025572.
DOI: 10.1021/bi500175p.
